Pharmacokinetics and Safety of SAR441236
Stopped early · Phase 1 · Has a placebo group
Conditions studied: HIV-1-infection
In brief
The purpose of this study was to evaluate the safety, tolerability, pharmacokinetics, and antiviral activity of SAR441236, a tri-specific broadly neutralizing antibody against the human immunodeficiency virus (HIV).
Key facts
- Study ID
- NCT03705169
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
- People needed
- 52
- Starts
- 2019-05-20
- Expected to finish
- 2022-04-04
- Last updated by the study team
- 2024-01-12
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Alabama CRS — Birmingham, Alabama, United States
- UCLA CARE Center CRS — Los Angeles, California, United States
- UCSD Antiviral Research Center CRS — San Diego, California, United States
- Ucsf Hiv/Aids Crs — San Francisco, California, United States
- University of Colorado Hospital CRS — Aurora, Colorado, United States
- Northwestern University CRS — Chicago, Illinois, United States
- Rush University CRS — Chicago, Illinois, United States
- Massachusetts General Hospital CRS (MGH CRS) — Boston, Massachusetts, United States
- Brigham and Women's Hospital Therapeutics Clinical Research Site (BWH TCRS) CRS — Boston, Massachusetts, United States
- Washington University Therapeutics (WT) CRS — St Louis, Missouri, United States
- New Jersey Medical School Clinical Research Center CRS — Newark, New Jersey, United States
- Weill Cornell Chelsea CRS — New York, New York, United States
- Weill Cornell Uptown CRS — New York, New York, United States
- University of Rochester Adult HIV Therapeutic Strategies Network CRS — Rochester, New York, United States
- Chapel Hill CRS — Chapel Hill, North Carolina, United States
- Cincinnati Clinical Research Site — Cincinnati, Ohio, United States
- Case Clinical Research Site — Cleveland, Ohio, United States
- Ohio State University CRS — Columbus, Ohio, United States
- Penn Therapeutics, CRS — Philadelphia, Pennsylvania, United States
- University of Pittsburgh CRS — Pittsburgh, Pennsylvania, United States
- The Miriam Hospital Clinical Research Site (TMH CRS) CRS — Providence, Rhode Island, United States
- Vanderbilt Therapeutics (VT) CRS — Nashville, Tennessee, United States
- University of Washington Positive Research CRS — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.